ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

OTLK Outlook Therapeutics Inc

7.07
-0.15 (-2.08%)
2024年6月1日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Outlook Therapeutics Inc OTLK NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.15 -2.08% 7.07 09:00:00
始値 安値 高値 終値 前日終値
7.26 6.89 7.35 7.07 7.22
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/2821:05GLOBEOutlook Therapeutics® Receives European Commission Marketing..
2024/5/1606:19EDGAR2Form 8-K - Current report
2024/5/1606:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/1606:00GLOBEOutlook Therapeutics® Reports Financial Results for Second..
2024/5/1405:05EDGAR2Form 8-K - Current report
2024/5/1321:50GLOBEOutlook Therapeutics® Announces UK Submission of Marketing..
2024/5/0921:45GLOBEOutlook Therapeutics® to Report Financial Results for Second..
2024/5/0713:15EDGAR2Form EFFECT - Notice of Effectiveness
2024/5/0705:09EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/5/0222:05GLOBEOutlook Therapeutics® to Present at the Retina World..
2024/4/2922:00GLOBEOutlook Therapeutics® to Present at the Ophthalmology..
2024/4/1605:15GLOBEOutlook Therapeutics® Announces Closing of Private Placement..
2024/3/2220:35GLOBEOutlook Therapeutics® Receives European Union Positive CHMP..
2024/3/1906:10GLOBEOutlook Therapeutics® Announces Closing of Private Placement..
2024/3/1221:05GLOBEOutlook Therapeutics® Announces Effective Date for 1-for-20..
2024/3/1205:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0906:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0906:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0906:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0906:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0806:16EDGAR2Form 8-K - Current report
2024/2/1507:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/2/1506:40EDGAR2Form 8-K - Current report
2024/2/1422:05GLOBEOutlook Therapeutics® Reports Financial Results for First..
2024/2/0820:59EDGAR2Form DEF 14A - Other definitive proxy statements
2024/2/0106:01EDGAR2Form SC 13D/A - General statement of acquisition of..
2024/1/3122:05GLOBEOutlook Therapeutics® Doses First Subject in NORSE EIGHT
2024/1/3007:00EDGAR2Form PRE 14A - Other preliminary proxy statements
2024/1/2507:00EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
2024/1/2420:02EDGAR2Form 8-K - Current report
2024/1/2322:00GLOBEOutlook Therapeutics® Receives FDA Agreement Under Special..
2023/12/2307:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2023/12/2306:15EDGAR2Form 8-K - Current report
2023/12/2222:05GLOBEOutlook Therapeutics® Reports Financial Results for Fiscal..
2023/12/1922:05GLOBEOutlook Therapeutics® Submits Special Protocol Assessment..
2023/12/1819:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
2023/12/0707:00EDGAR2Form 8-K - Current report
2023/12/0622:05GLOBEOutlook Therapeutics® Announces Strategic Organizational..
2023/12/0419:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
2023/11/3006:01EDGAR2Form SC 13D/A - General statement of acquisition of..
2023/11/2819:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
2023/11/2722:05GLOBEOutlook Therapeutics® Announces Receipt of Type A Meeting..
2023/11/2119:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
2023/11/1422:05GLOBEOutlook Therapeutics® Adds Global Commercial Expertise with..
2023/11/1419:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
2023/11/0221:12EDGAR2Form 8-K - Current report
2023/11/0221:05GLOBEOutlook Therapeutics® Provides Update on Type A Meetings..
2023/11/0121:05GLOBEOutlook Therapeutics® to Present at Guggenheim’s 5th Annual..
2023/10/2106:00EDGAR2Form 8-K - Current report
2023/10/0606:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..

最近閲覧した銘柄

Delayed Upgrade Clock